PubRank

I Penn

Author PubWeight™ 167.86‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. N Engl J Med 1994 7.96
2 Orthotopic homotransplantation of the human liver. Ann Surg 1968 6.64
3 Cyclophosphamide and whole organ transplantation in human beings. Surg Gynecol Obstet 1971 5.24
4 Malignant lymphomas in transplantation patients. Transplant Proc 1969 4.12
5 Long-term survival after renal transplantation in humans: (with special reference to histocompatibility matching, thymectomy, homograft glomerulonephritis, heterologous ALG , AND RECIPIENT MALIGNANCY). Ann Surg 1970 3.48
6 Delayed biliary duct obstruction after orthotopic liver transplantation. Surgery 1972 3.26
7 De novo malignant tumors in organ transplant recipients. Transplant Proc 1971 3.03
8 Iatrogenic alterations of immunologic surveillance in man and their influence on malignancy. Transplant Rev 1971 2.94
9 Studies of homograft sex and of gamma globulin phenotypes after orthotopic homotransplantation of the human liver. Surg Forum 1969 2.80
10 De-novo brain tumours in renal-transplant recipients. Lancet 1971 2.36
11 Immunosuppression, liver injury, and hepatitis in renal, hepatic, and cardiac homograft recipients: with particular reference to the Australia antigen. Ann Surg 1971 2.14
12 Intravascular ultrasound-guided optimized stent deployment. Immediate and 6 months clinical and angiographic results from the Multicenter Ultrasound Stenting in Coronaries Study (MUSIC Study) Eur Heart J 1998 1.95
13 Urological complications in 216 human recipients of renal transplants. Ann Surg 1970 1.90
14 Malignant tumors arising de novo in immunosuppressed organ transplant recipients. Transplantation 1972 1.80
15 Liver transplantation for cholangiocarcinoma: results in 207 patients. Transplantation 2000 1.79
16 Hemodynamic alterations caused during orthotopic liver transplantation in humans. Surgery 1971 1.79
17 Cyclophosphamide and human organ transplantation. Lancet 1971 1.77
18 Kaposi's sarcoma in organ transplant recipients: report of 20 cases. Transplantation 1979 1.64
19 Tumor incidence in human allograft recipients. Transplant Proc 1979 1.64
20 Renal homotransplantation in pediatric patients. Pediatrics 1971 1.59
21 Cancers of the anogenital region in renal transplant recipients. Analysis of 65 cases. Cancer 1986 1.58
22 Cancers following cyclosporine therapy. Transplantation 1987 1.57
23 Cancers complicating organ transplantation. N Engl J Med 1990 1.57
24 Bypass surgery versus stenting for the treatment of multivessel disease in patients with unstable angina compared with stable angina. Circulation 2002 1.56
25 Surgically correctable intra-abdominal complications before and after renal homotransplantation. Ann Surg 1968 1.56
26 A trial with heterologous antilymphocyte globulin in man. Transplant Proc 1969 1.51
27 Clinical and pathologic observations after orthotopic transplantation of the human liver. Surg Gynecol Obstet 1969 1.51
28 Parenthood following renal and hepatic transplantation. Transplantation 1980 1.35
29 Major colonic problems in human homotransplant recipients. Arch Surg 1970 1.33
30 Malignancies associated with immunosuppressive or cytotoxic therapy. Surgery 1978 1.32
31 Disappearance rates and immunosuppression of intermittent intravenously administered prednisolone in rabbits and human beings. Surg Gynecol Obstet 1970 1.32
32 Gynecologic malignancies in immunosuppressed organ homograft recipients. Obstet Gynecol 1975 1.32
33 Human renal transplants. 3. Immunopathologic studies. Lab Invest 1970 1.31
34 The price of immunotherapy. Curr Probl Surg 1981 1.29
35 Immunosuppression and cancer. Transplant Proc 1973 1.26
36 Malignant neoplasms following cardiac transplantation. JAMA 1978 1.24
37 Parenthood in renal homograft recipients. JAMA 1971 1.24
38 Acute pancreatitis and hyperamylasemia in renal homograft recipients. Arch Surg 1972 1.24
39 Cutaneous complications in immunosuppressed renal homograft recipients. JAMA 1974 1.21
40 Perspectives in organ transplantation. Antibiot Chemother 1969 1.19
41 Immunosuppression and malignant neoplasms. N Engl J Med 1970 1.18
42 Depressed immunity and the development of cancer. Clin Exp Immunol 1981 1.17
43 Second malignant neoplasms associated with immunosuppressive medications. Cancer 1976 1.16
44 A decade followup in early cases of renal homotransplantation. Ann Surg 1974 1.16
45 Clinical liver transplantation. Transplant Rev 1969 1.13
46 The occurrence of malignant tumors in immunosuppressed states. Prog Allergy 1986 1.13
47 Occurrence of cancer in immune deficiencies. Cancer 1974 1.10
48 Immunopathological studies of orthotopic human liver allografts. Lancet 1972 1.07
49 Parenthood in kidney and liver transplant recipients. Transplant Proc 1981 1.06
50 Cancer is a complication of severe immunosuppression. Surg Gynecol Obstet 1986 1.06
51 Tumors arising in organ transplant recipients. Adv Cancer Res 1978 1.04
52 Use of living donors in kidney transplantation in man. Arch Surg 1970 1.04
53 Cyclophosphamide for clinical renal and hepatic transplantation. Transplant Proc 1973 1.04
54 Cerebral neoplasms associated with renal transplantation. Arch Neurol 1970 1.03
55 Air embolism after central venous catheterization. Surg Gynecol Obstet 1984 1.03
56 Results of renal transplantation in patients with renal cell carcinoma and von Hippel-Lindau disease. Transplantation 1997 1.03
57 Transplantation of kidneys containing primary malignant tumors. Transplantation 1973 1.02
58 Indications for orthotopic liver transplantation: with particular reference to hepatomas, biliary atresia, cirrhosis, Wilson's disease and serum hepatitis. Transplant Proc 1971 1.00
59 Airless paint gun injuries of the hand: a clinical and experimental study. Plast Reconstr Surg 1967 0.99
60 Malignancies associated with renal transplantation. Urology 1977 0.99
61 The fate of failed renal homografts retained after retransplantation. Surg Gynecol Obstet 1973 0.98
62 Development of cancer as a complication of clinical transplantation. Transplant Proc 1977 0.98
63 Thymectomy and renal homotransplantation. Clin Exp Immunol 1970 0.98
64 Jejunal rupture caused by a Sengstaken-Blakemore tube. Gastroenterology 1982 0.97
65 Net histocompatibility ratios (NHR) for clinical transplantation. Transplant Proc 1971 0.97
66 Personal experience with orthotopic liver transplantation. Transplant Proc 1972 0.96
67 The effect of hyperbaric oxygen upon aerobic bacteria. I. In vitro studies. Can J Microbiol 1966 0.95
68 Proteinuria following transplantation. Correlation with histopathology and outcome. Transplantation 1984 0.94
69 Renal transplantation for Wilms tumor: report of 20 cases. J Urol 1979 0.94
70 Carcinoid tumor of the biliary system. Case report and literature review. Dig Dis Sci 1987 0.93
71 Cancer in immunosuppressed patients. Transplant Proc 1984 0.93
72 Malignant lymphomas in transplantation patients: a review of the world experience. Int Z Klin Pharmakol Ther Toxikol 1970 0.93
73 The incidence of malignancies in transplant recipients. Transplant Proc 1975 0.93
74 Parenthood following renal transplantation. Kidney Int 1980 0.93
75 Efficacy of coronary stenting versus balloon angioplasty in small coronary arteries. Stent Restenosis Study (STRESS) Investigators. J Am Coll Cardiol 1998 0.93
76 Chemical immunosuppression and human cancer. Cancer 1974 0.93
77 Antimurine antibody formation following OKT3 therapy. Transplantation 1990 0.91
78 Eight- to ten-year follow-up in early cases of renal homotransplantation. Transplant Proc 1973 0.91
79 Psychiatric experience with patients receiving renal nad hepatic transplants. Semin Psychiatry 1971 0.90
80 Malignant lymphomas in organ transplant recipients. Transplant Proc 1981 0.89
81 Psychiatric aspects of hepatic transplantation. Transplantation 1983 0.89
82 A summary of the status of de novo cancer in transplant recipients. Transplant Proc 1972 0.88
83 Cyclosporine and oncogenesis. Mt Sinai J Med 1987 0.87
84 Fate of tumors transplanted with a renal allograft. Transplant Proc 1975 0.86
85 Peritoneal metastasis of intracranial glioblastoma via a ventriculoperitoneal shunt preventing organ retrieval: case report and review of the literature. Clin Transplant 1998 0.86
86 Renal transplantation exposes patients with previous Kaposi's sarcoma to a high risk of recurrence. Transplantation 1996 0.86
87 Development and incidence of cancer following cyclosporine therapy. Transplant Proc 1986 0.86
88 Upper extremity complications of axillofemoral grafts. Am J Surg 1978 0.85
89 The prospect of organ transplantation in cancer surgery. Proc Natl Cancer Conf 1970 0.85
90 Hyperparathyroidism following parathyroid autotransplantation. Surgery 1979 0.85
91 Kaposi's sarcoma in immunosuppressed patients. J Clin Lab Immunol 1983 0.84
92 Clinical course of malignancies in renal transplant recipients. Cancer 1993 0.84
93 Development of cancer in transplantation patients. Adv Surg 1978 0.83
94 Selected topics on antilymphocyte serum. Fed Proc 1970 0.83
95 Testicular complications following renal transplantation. Ann Surg 1972 0.83
96 The induction of immunologic hyporesponsiveness by preoperative donor-specific transfusions and cyclosporine in human cadaveric transplants. A preliminary trial. Transplantation 1992 0.82
97 Solid tumors in cardiac allograft recipients. Ann Thorac Surg 1995 0.82
98 Skin disorders in organ transplant recipients. External anogenital lesions. Arch Dermatol 1997 0.82
99 HPV subtype analysis in lower genital tract neoplasms of female renal transplant recipients. Gynecol Oncol 2000 0.82
100 A reappraisal of the microcirculation during general hypothermia. Surgery 1965 0.82
101 Immunosuppression and skin cancer. Clin Plast Surg 1980 0.81
102 The declining role of the surgeon in the treatment of acid-peptic diseases. Arch Surg 1980 0.81
103 Successful retreatment of allograft rejection with OKT3. Transplantation 1989 0.80
104 Portal vein gas and sepsis after administration of OKT3. Lancet 1987 0.80
105 Penetrating injuries of the neck. Surg Clin North Am 1973 0.80
106 Testicular seminoma originating in an undescended testis in a renal allograft recipient. Urology 1996 0.79
107 The occurrence of cancer in immune deficiencies. Curr Probl Cancer 1982 0.79
108 Organ transplantation, past and present. Surg Clin North Am 1968 0.79
109 Squamous cell carcinoma of the skin and lip in renal homograft recipients. Cancer 1976 0.78
110 Accelerated induction of skin cancers by ultraviolet radiation in hairless mice treated with immunosuppressive agents. Surg Forum 1975 0.78
111 Host origin of lymphomas in organ transplant recipients. Transplantation 1979 0.78
112 Lidocaine metabolism as an index of liver function in hepatic transplant donors and recipients. Transplant Proc 1989 0.78
113 Second neoplasms following radiotherapy or chemotherapy for cancer. Am J Clin Oncol 1982 0.78
114 Immunosuppression and the development of malignancies of the upper airway and related structures. Laryngoscope 1981 0.78
115 Protein S deficiency and skin necrosis associated with continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1992 0.77
116 Current experience with renal transplantation in older patients. Am J Kidney Dis 1988 0.77
117 Leukemias and lymphomas associated with the use of cytotoxic and immunosuppressive drugs. Recent Results Cancer Res 1979 0.77
118 Recent contributions to transplantation at the University of Cincinnati. Clin Transpl 1991 0.77
119 Inflammatory polyposis in an ileal blind loop. Gastroenterology 1983 0.77
120 Cancer in organ transplant recipients. Prog Clin Cancer 1975 0.77
121 Some contributions of transplantation to our knowledge of cancer. Transplant Proc 1980 0.76
122 Unsuccessful attempts to control hyperacute rejection of human renal homografts with F(ab') 2 and citrate organ pretreatment. Transplantation 1973 0.76
123 Orthotopic liver transplantation in man. Transplant Proc 1969 0.76
124 Immunosuppression and cancer. Importance in head and neck surgery. Arch Otolaryngol 1975 0.76
125 Prophylactic use of OKT3 in immunologic high-risk cadaver renal transplant recipients. Am J Kidney Dis 1989 0.76
126 Oral presentation of posttransplantation lymphoproliferative disorders. An unusual manifestation. Transplantation 1996 0.75
127 Dormant metastases. Can J Surg 1991 0.75
128 Proceedings: The effect of immunosuppression on cancer. Proc Natl Cancer Conf 1972 0.75
129 Malignancy in transplanted organs. Transpl Int 1993 0.75
130 Anesthesia experience with living renal transplant donors. Anesth Analg 1971 0.75
131 Renal transplantation under cyclophosphamide. Transplant Proc 1972 0.75
132 Pulmonary surgery in immunosuppressed patients. J Thorac Cardiovasc Surg 1970 0.75
133 Immunosuppression and Neoplasia. Behring Inst Mitt 1972 0.75
134 Proceedings: Transplantation of extrarenal organs. Proc Natl Cancer Conf 1972 0.75
135 Paraffin oil. Lancet 1973 0.75
136 Selection criteria for liver transplant donors. J Clin Lab Anal 1991 0.75
137 The use of hyperbaric oxygen in experimental renal ischemia. Can J Surg 1967 0.75
138 Autotransplantation of parathyroid adenoma. N Engl J Med 1979 0.75
139 Prednisone withdrawal in HLA-identical living related donor transplant recipients. Transplant Proc 1989 0.75
140 Effect of arterial stenosis on the distribution of induced atheroarteriosclerosis. Surgery 1966 0.75
141 Risk of lymphoma after cardiac transplantation. Lancet 1979 0.75
142 Immunologically privileged brain sites. JAMA 1972 0.75
143 An evaluation of the effect of powdered collagen on the healing of experimental bone defects. Can J Surg 1965 0.75
144 Complications of immunosuppression. Minerva Chir 1971 0.75
145 The effect of therapeutic agents upon the microcirculation during general hypothermia. Surgery 1966 0.75
146 Multiple myeloma in a renal transplant recipient. Am J Kidney Dis 1988 0.75
147 Cancer in cadaver kidney transplant patients. Surgery 1984 0.75
148 Clinical experience with horse antihuman ALG. Transplant Proc 1972 0.75
149 Tumors in allograft recipients. N Engl J Med 1979 0.75
150 Effects of treatment with hyperbaric oxygen. Manit Med Rev 1966 0.75
151 Transplantation in patients with primary renal malignancies. Transplantation 1977 0.75
152 Hemodynamic changes in clinical orthotopic liver transplantation. Surg Forum 1971 0.75
153 Malignancies in recipients of organ transplants. Johns Hopkins Med J Suppl 1974 0.75
154 Psychiatric considerations in renal transplant surgery. Psychosomatics 1980 0.75
155 Immune monitoring during retreatment with OKT3. Transplant Proc 1989 0.75
156 Management of the perforated duodenal ulcer. Heart Lung 1978 0.75
157 Misdiagnosis of metastatic cerebral choriocarcinoma in female cadaver donors. Transplant Proc 1988 0.75
158 HLA and Kaposi's sarcoma in solid organ transplantation. Hum Immunol 1990 0.75
159 Request for specimens from organ transplant and immunodeficiency patients who developed lymphomas. Cancer Res 1979 0.75
160 Malignant disease in immunodeficient states in man. Recent Results Cancer Res 1975 0.75
161 Malignancies induced by drug therapy: a review. IARC Sci Publ 1986 0.75
162 Evaluation of oxisuran as an immunosuppressive agent. Proc Soc Exp Biol Med 1974 0.75
163 Pseudolymphoma in renal allograft recipients. Arch Surg 1979 0.75
164 Cyclosporine-associated glomerular and arteriolar thrombosis following renal transplantation. Transplant Proc 1989 0.75
165 The use of low doses of cyclosporine, azathioprine, and prednisone in renal transplantation. Transplant Proc 1986 0.75
166 Efficacy of induction therapy in cadaveric renal transplantation comparing rabbit antithymocyte serum and Minnesota antilymphoblast globulin. Transplant Proc 1991 0.75
167 Hepatocellular carcinoma associated with chronic hepatitis B virus infection after kidney transplantation. Lancet 1982 0.75
168 The effect of hyperbaric oxygen on L-noradrenaline-induced myocardial necrosis. Can J Surg 1966 0.75